These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2422855)

  • 41. [Obtaining dysentery and salmonellosis diagnostica for the coagglutination reaction in lyophilized form and the elaboration of a rapid system].
    Belaia IuA; Belaia OF
    Lab Delo; 1982; (8):486-8. PubMed ID: 6182376
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of using the indirect hemagglutination test and Tsuverkalov's test in the diagnosis of dysentery].
    Smetanin VN; Zamotin BA
    Tr Inst Im Pastera; 1981; 56():56-8. PubMed ID: 6764972
    [No Abstract]   [Full Text] [Related]  

  • 44. [New methodological approaches to the use of the PHA reaction in determining anti-Shigella antibodies].
    Kaplin VN; Koriukina IP; Shliapnikova LN; Shalgina LV; Luzina GI; Dvorianskaia SV; Kuznetsov VF; Iurganova GA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):79-83. PubMed ID: 7778383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical trials of Shigella vaccines in Israel.
    Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
    Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
    [No Abstract]   [Full Text] [Related]  

  • 48. [Serological method of detecting the antigens of the causative agent of Sonne dysentery in lysates of the fecal inoculates from patients].
    Seppi IV; Levi MI; Stepanova SL; Mel'nik EG; Amirkhanova AV
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):31-6. PubMed ID: 352065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Assessment of the diagnostic effectiveness of antigenic preparations from Sonne shigellae].
    Sumarokov AA; Nikitiuk NM; Bardzilauskene AP; Bodiu VI; Mil'ner EM
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):79-86. PubMed ID: 339617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnostic test system for the quantitative determination of Shigella antigens in patient blood by an immunoenzyme analytical method].
    Shabalina SV; Abdurakhmanova EG; Timina VP
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):64-7. PubMed ID: 6362300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antibody against Shigella in bacillary dysentery patients and carriers. I. Sonne-dysentery].
    Miyata Y; Kitaura T; Hirakata T; Kakamura M; Sugiyama S
    Nihon Densenbyo Gakkai Zasshi; 1969 Dec; 43(9):217-24. PubMed ID: 4983206
    [No Abstract]   [Full Text] [Related]  

  • 52. [Dissociation and phagolytic characteristics of the Shigella isolated from patients with various clinical forms of dysentery].
    Shibacheva NN; Voskun SE
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Dec; (12):34-7. PubMed ID: 6364654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of the mechanism of formation of protracted forms of dysentery].
    Suptel' EA; Moshchich PS; Borisov VA; Zagornaia NB; Pavlovich SI
    Vrach Delo; 1978 Dec; (12):115-8. PubMed ID: 369138
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of passive hemagglutination inhibition test for diagnosis of Sonne dysentery under conditions of practical laboratory].
    Rybakova NA
    Lab Delo; 1975; (3):168-70. PubMed ID: 48595
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical and treatment characteristics of acute dysentery caused by Shigella boydii and newcastle].
    Mel'nik GV
    Vrach Delo; 1984 Aug; (8):114-7. PubMed ID: 6390958
    [No Abstract]   [Full Text] [Related]  

  • 59. Protective milk O antibodies induced in guinea pigs by parenteral Shigella ribosomal vaccine.
    Chernokhvostova EV; Lyubinskaya MM; Belkin ZP; Levenson VI
    Int Arch Allergy Appl Immunol; 1990; 92(3):265-7. PubMed ID: 2276843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.